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Abstract 
Aneuploidy, defined as an alteration in chromosome number that is not a multiple of the 
haploid complement, severely affects cellular physiology. Changes in chromosome 
number lead to imbalances in cellular protein composition, thus disrupting cellular 
processes and causing proteins to misfold and aggregate. We recently reported that in 
mammalian cells protein aggregates are readily encapsulated within autophagosomes 
but are not degraded by lysosomes. This leads to a lysosomal stress response in which 
the transcription factor TFEB induces expression of factors needed for macroautophagy-
mediated protein degradation. Our studies uncover lysosomal degradation defects as a 
feature of the aneuploid state, and a role for the transcription factor TFEB in the 
response thereto. 
 
 The changes in gene copy number brought about by aneuploidy translate into 
changes in protein expression. This leads to dramatic alterations in the cell’s protein 
composition. It has been proposed that the altered protein composition of aneuploid cells 
causes increased protein misfolding and aggregation, and proteotoxic stress ensues. To 
gain insights into how increased protein misfolding affects the protein quality control 
pathways of aneuploid cells we investigated the consequences of chromosome mis-
segregation and aneuploidy on one of the cell’s protein quality control pathways, 
macroautophagy (hereafter autophagy). We found that following chromosome mis-
segregation, autophagosomal constituents accumulate within lysosomes. Analysis of 
lysosomal function did not reveal any substantive defects. Lysosomal pH and catalytic 
activity of cathepsins does not appear impaired in aneuploid cells raising the possibility 
that autophagosomal content is not effectively cleared because lysosomal capacity is 
limiting rather than compromised. Our studies further suggested that it is protein 
aggregate-containing autophagosomes that accumulate in the lysosomal compartment. 
We found SQSTM1/p62, which serves as a protein aggregate receptor in autophagy, to 
accumulate in lysosomes. Electron microscopy analysis further showed that 
autolysosomes were filled with electron-dense material. Together, our findings indicate 
that aneuploidy has a dramatic impact on the degradative capacity of the lysosomal 
compartment. It will be interesting to define which proteins aggregate in aneuploid cells 
and whether it is specific protein aggregates that accumulate within lysosomes. Whether 
autophagic cargo other than protein aggregates such as mitochondria accumulates in 
the lysosomal compartment in aneuploid cells also remains to be determined.  
 Cells respond to the accumulation of autophagic cargo in lysosomes. Upon 
chromosome mis-segregation we observed translocation of the transcription factor TFEB 
into the nucleus and a concomitant upregulation of TFEB-responsive genes. Our data 
further showed that inhibition of proteasomal degradation also leads to TFEB activation 
indicating that aggregated/misfolded proteins can activate TFEB. A key question that 
remains to be addressed is how aneuploidy controls TFEB activity. Previous studies 
showed that proteasome inhibition induces autophagy because internal amino acid pools 
are depleted when protein recycling by the proteasome is inhibited. TFEB could be 
regulated by this same mechanism. Changes in TFEB’s subcellular localization are 
accompanied by changes in TFEB phosphorylation, indicating that this posttranslational 
modification regulates TFEB’s localization in the cell. Furthermore TORC1, the protein 
kinase complex that is regulated by amino acid availability, controls TFEB 
phosphorylation and localization. Whether TFEB is activated by this mechanism in 
aneuploid cells is not known. Our preliminary data indicate that TORC1 is not 
responsible for TFEB activation in response to chromosome mis-segregation, which 
leads us to speculate that other signals are responsible for controlling TFEB activity in 
response to lysosome saturation in aneuploid cells. Identifying the protein kinase(s) that 
targets TFEB in response to cargo accumulation in the lysosome will be essential in 
elucidating the mechanism whereby aneuploidy activates the transcription factor. 
 In summary, our study provides evidence that, in mammalian cells, aneuploidy 
limits lysosomal capacity. This defect does not manifest itself immediately after 
chromosome mis-segregation, but require 2-3 cell divisions to become apparent. This 
finding suggests that lysosomal defects are not an immediate consequence of 
aneuploidy, but require the continuous presence of an aneuploid karyotype and the 
proteomic imbalances associated with it. We propose that cells have a maximal 
degradative capacity that is reached by the persistence of misfolded and/or aggregated 
proteins (Fig. 1A). When this maximal degradative capacity is reached, a lysosomal 
stress response ensues that is aimed at producing more autophagosomes and 
lysosomes (Fig. 1B).  
 Our analysis focused on the effects of aneuploidy on autophagy in primary cells. 
It will be interesting to determine whether chromosome mis-segregation and aneuploidy 
cause lysosomal saturation in cancer cells. Cancer cells harbor high levels of aneuploidy 
and are genomically unstable with karyotypes changing continuously. This places a 
profound pressure on the protein quality control machinery of aneuploid cells. Indeed, 
cancer cells have previously been shown to not only depend on protein quality control 
mechanisms for their survival but to also upregulate their protein folding machinery. It is 
thus not unlikely that other protein quality control pathways such as autophagy are also 
more active in aneuploid cancer cells. Indeed our preliminary studies suggest that many 
aneuploid cancer cell lines do not experience lysosomal saturation following 
chromosome mis-segregation. This result raises the interesting possibility that one 
aspect of malignant transformation is the development of mechanisms that allow cells to 
upregulate lysosomal capacity, perhaps by upregulating TFEB activity. Addressing the 
importance of autophagic degradation for tumorigenesis and determining whether and 
how autophagic activity is altered in aneuploid cells will be an important future question. 
The observation that RAS-driven and BRAF-driven cancers upregulate autophagy and 
are dependent on autophagic degradation for survival already points toward this protein 
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Figure 1. A model as to how proteotoxic load induces a lysosomal stress response.  
An increasing load of misfolded and/or aggregated proteins brought about by aneuploidy 
causes lysosome-mediated protein degradation to become limiting (A). This in turn 
triggers a lysosomal stress response, which lead to translocation of the transcription 
factor TFEB from the cytoplasm into the nucleus where it stimulates the transcription of 
genes involved in autophagic degradation (B).  
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